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Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United StatesThe products of the 19 Fanconi anemia (FA) genes play important
and often biochemically collaborative roles in the repair of DNA
interstrand crosslinks and regulation of cellular responses to the
genotoxic stress imposed by cellular replication. In response to exog-
enous and endogenous (e.g. aldehydes) cross-linking agents, large
multimeric nuclear FA “core complex” proteins facilitate the mono-
ubiquitinylation of FANCD2 and FANCI, post-translational changes
required for resolution of stalled replication forks, removal of inter-
strand cross-links and promotion of homologous recombination.
Other members of the FA family of proteins function “downstream”
of FANCD2 and FANCI and also participate in other nuclear functions
(e.g. promoting telomere maintenance) (Kim et al., 2013). Biallelelic
inactivation of these genes results in the rare inherited disease,
Fanconi anemia, a disorder characterized by various developmental
anomalies, bone marrow failure, leukemia, and epithelial malignan-
cies (Bogliolo and Surralles, 2015). In some cases (FANCD1, FANCJ,
FANCM, FANCN, FANCO and FANCS) monoallelic inactivation predis-
poses individuals to breast and ovarian cancer. While the prevalence
of Fanconi anemia is about 1–9 per million, the constellation of clin-
ical ﬁndings and their apparently disparate pathophysiologies has
permitted studies on this disease to inform the broad ﬁelds of hema-
topoiesis, development, and carcinogenesis. It is now clear that at
least some of these proteins function to protect stem cells from dam-
age imposed on them by inﬂammatory and oxidative stress and do so
in ways that do not necessarily rely upon unique canonical nuclear
functions (Sumpter et al., 2016).
FA hematopoietic stem and progenitor cells (HSPC) exhibit unique
sensitivities to both oxidative stress and inﬂammatory cytokines
(Haneline et al., 1998). Moreover, innate immune cells bearing FA mu-
tations exhibit abnormal mitophagic and virophagic responses as well
as abnormally robust responses to toll-like receptor activation all of
which can result in the overproduction of precisely those cytokines to
which FA HSPC are hypersensitive (Garbati et al., 2016; Sumpter et al.,
2016). Murine models of FA did not initially demonstrate key features
of the FA phenotype (marrow failure, spontaneous leukemia, and
cancer) but once inﬂammatory stresswas applied thephenotype of pro-
gressive and fatal bone marrow failure was provoked (Walter et al.,
2015), and it became clear that the murine models will be enormously
helpful in sorting out the heterogeneous features of the disease by
linking themwith particular functions of thesemultifunctional proteins.DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.05.055.
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inﬂammatory processes? The work of Brégnard et al. in this issue of
EBioMedicine (Brégnard et al., 2016) supports that notion. Because the
FA phenotype involves both cytokine overproduction and a deﬁcient
DNA damage response, they reasoned that the damage response
might result in excess nucleic acid loads in cellular compartments that
permit recognition by proteins designed to recognize pathogen associ-
ated molecular patterns. Indeed, they found that loss of the FANCP or
FANCD2 genes results in the accumulation of cytoplasmic DNA which
then triggers the cGAS-STING pathway and interferon production.
Interestingly, this phenomenon has been likewise reported in the
inherited disease Ataxia Telangiectasia, a cancer predisposition syn-
drome characterized by heterogeneous inﬂammatory manifestations.
In cells from patients and from Atm−/−mice, unrepaired DNA lesions
induce type I interferons (IFNs). Activation of the type I interferon
system involved accumulation of cytoplasmic DNA where it activates
the STING-mediated pathway, and activates expression of RIG-I-like
receptors and Toll-like receptors (Hartlova et al., 2015). Both of these
studies provide a potential mechanistic link between the inﬂammatory
phenotype of AT and FA patients and the DNA damage phenotype. It
should be mentioned that the inﬂammatory process incited in these
studies by cytoplasmic DNA can play an important role in cancer
progression (Krelin et al., 2007).
Brégnard et al. also discovered that some of the cytoplasmic DNA
resulted from enhanced LINE-1 retrotransposition, a phenomenon
others have associated with inﬂammatory diseases (Volkman and
Stetson, 2014). That inhibitors of reverse transcription diminished
cytokine production in the FA cells is compatible with the view that
these FA proteins function in some way to constrain endogenous re-
verse transcriptase activities, preventing accumulation of cytoplasmic
nucleic acids thereby suppressing the activation of cytokine gene tran-
scription. Therefore, this new pathway by which the inﬂammatory re-
sponse participates in the Fanconi anemia phenotype may hold some
therapeutic potential. While more work is required on the precise
mechanisms by which FA proteins might constrain cytoplasmic accu-
mulation of endogenous nucleic acids, and while the downsides of
reverse transcriptase inhibitors need to be investigated carefully in pri-
mary FA cells, the possibility that such agents might inhibit aberrant
constitutive activation of the inﬂammatory response is intriguing and,
given the important role this response plays in disease pathogenesis,
the use of such agents clinically may have some potential. Because
inﬂammation can result in DNA damage and vice versa, the use of
such inhibitors in preclinical models might also permit investigators in
the ﬁeld to sort out the order of events in Fanconi anemia pathogenesis.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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